Legal & General Group
IMCR icon

Legal & General Group’s Immunocore IMCR Stock Holding History

Legal & General Group’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.51M Buy
299,670
+143,527
+92% +$4.25M ﹤0.01% 1201
2026
Q1 		$4.7M Buy
156,143
+6,810
+5% +$220K ﹤0.01% 1532
2025
Q4 		$5.18M Buy
149,333
+23,577
+19% +$832K ﹤0.01% 1544
2025
Q3 		$4.56M Buy
125,756
+2,517
+2% +$85.5K ﹤0.01% 1629
2025
Q2 		$3.87M Sell
123,239
-18,436
-13% -$573K ﹤0.01% 1664
2025
Q1 		$4.2M Buy
141,675
+4,800
+4% +$144K ﹤0.01% 1608
2024
Q4 		$4.04M Buy
136,875
+20,163
+17% +$637K ﹤0.01% 1682
2024
Q3 		$3.63M Sell
116,712
-3,805
-3% -$138K ﹤0.01% 1719
2024
Q2 		$4.08M Buy
120,517
+84,472
+234% +$4.31M ﹤0.01% 1624
2024
Q1 		$2.34M Sell
36,045
-250
-0.7% -$17.2K ﹤0.01% 1873
2023
Q4 		$2.48M Buy
36,295
+8,609
+31% +$447K ﹤0.01% 1844
2023
Q3 		$1.44M Buy
27,686
+3,712
+15% +$220K ﹤0.01% 2044
2023
Q2 		$1.44M Buy
23,974
+17,920
+296% +$1.02M ﹤0.01% 2071
2023
Q1 		$299K Buy
6,054
+304
+5% +$17.1K ﹤0.01% 2450
2022
Q4 		$328K Sell
5,750
-9,599
-63% -$540K ﹤0.01% 2439
2022
Q3 		$719K Sell
15,349
-443
-3% -$21.1K ﹤0.01% 2246
2022
Q2 		$589K Sell
15,792
-6,577
-29% -$214K ﹤0.01% 2305
2022
Q1 		$667K Hold
22,369
– – ﹤0.01% 2322
2021
Q4 		$765K Sell
22,369
-2,908
-12% -$105K ﹤0.01% 2305
2021
Q3 		$933K Buy
25,277
+6,186
+32% +$209K ﹤0.01% 2265
2021
Q2 		$725K Buy
+19,091
New +$737K ﹤0.01% 2265

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Legal & General Group's IMCR Position: Q2 2026 in Review

Legal & General Group increased its Immunocore (IMCR) stake by 92% in Q2 2026, buying an estimated $4.25M and bringing the position to 299,670 shares worth $9.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Legal & General Group first reported a position in IMCR in Q2 2021 and has held it in 21 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Legal & General Group held 299,670 shares of Immunocore worth $9.51M as of Q2 2026.
  • Legal & General Group bought 143,527 Immunocore shares in Q2 2026, an estimated $4.25M.
  • Immunocore made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1201 holding.
  • Legal & General Group first reported a position in Immunocore in Q2 2021 and has held it in 21 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.